Trial Profile
A study to evaluate whether the intensity and frequency are the strongest predictors of treatment efficacy after Botox in patients with migraine.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Aug 2015
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Migraine
- Focus Therapeutic Use
- 17 Aug 2015 New trial record